Early definite stent thrombosis with everolimus-eluting stents.
Stent thrombosis (ST) is a serious complication of percutaneous coronary intervention. Several factors are associated with ST, and combination of these factors increase the risk, even in everolimus-eluting stents, which have low risk of ST. We experienced a case of ST caused by limited coronary flow and resistance to antiplatelet agent.
Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine Tokyo, Japan.
Ryo
R
Naito
Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine Tokyo, Japan.
Katsumi
K
Miyauchi
Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine Tokyo, Japan.
Hirokazu
H
Konishi
Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine Tokyo, Japan.
Shuta
S
Tsuboi
Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine Tokyo, Japan.
Shinya
S
Okazaki
Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine Tokyo, Japan.
Hiroyuki
H
Daida
CYP2C19 polymorphism; Coronary flow limitation; everolimus-eluting stent; stent thrombosis